As of 2026-05-15, the EV/EBITDA ratio of Imexpharm Corp (IMP.VN) is 13.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMP.VN's latest enterprise value is 7,369,863.00 mil VND. IMP.VN's TTM EBITDA according to its financial statements is 545,979.70 mil VND. Dividing these 2 quantities gives us the above IMP.VN EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 12.7x | 10.1x |
| Forward P/E multiples | 8.0x - 9.5x | 8.6x |
| Fair Price | 28,774.83 - 44,727.75 | 34,930.86 |
| Upside | -39.7% - -6.2% | -26.8% |
| Date | EV/EBITDA |
| 2026-05-14 | 13.51 |
| 2026-05-13 | 13.50 |
| 2026-05-12 | 13.26 |
| 2026-05-11 | 13.26 |
| 2026-05-08 | 13.61 |
| 2026-05-07 | 13.47 |
| 2026-05-06 | 13.92 |
| 2026-05-05 | 14.12 |
| 2026-05-04 | 14.12 |
| 2026-04-29 | 14.37 |
| 2026-04-28 | 13.44 |
| 2026-04-24 | 13.68 |
| 2026-04-23 | 14.09 |
| 2026-04-22 | 14.51 |
| 2026-04-21 | 15.59 |
| 2026-04-20 | 15.84 |
| 2026-04-17 | 15.90 |
| 2026-04-16 | 15.81 |
| 2026-04-15 | 15.81 |
| 2026-04-14 | 15.84 |
| 2026-04-13 | 15.81 |
| 2026-04-10 | 15.70 |
| 2026-04-09 | 15.73 |
| 2026-04-08 | 15.73 |
| 2026-04-07 | 15.70 |
| 2026-04-06 | 15.76 |
| 2026-04-03 | 15.76 |
| 2026-04-02 | 15.73 |
| 2026-04-01 | 15.76 |
| 2026-03-31 | 15.47 |
| 2026-03-30 | 15.56 |
| 2026-03-27 | 15.50 |
| 2026-03-26 | 15.42 |
| 2026-03-25 | 15.61 |
| 2026-03-24 | 15.56 |
| 2026-03-23 | 15.39 |
| 2026-03-20 | 15.42 |
| 2026-03-19 | 15.56 |
| 2026-03-18 | 15.59 |
| 2026-03-17 | 15.87 |
| 2026-03-16 | 15.73 |
| 2026-03-13 | 15.56 |
| 2026-03-12 | 15.87 |
| 2026-03-11 | 16.04 |
| 2026-03-10 | 15.95 |
| 2026-03-09 | 15.19 |
| 2026-03-06 | 15.25 |
| 2026-03-05 | 15.36 |
| 2026-03-04 | 15.33 |
| 2026-03-03 | 15.28 |